Literature DB >> 3499072

Torsade de pointes during administration of pentamidine isethionate.

J M Wharton1, P A Demopulos, N Goldschlager.   

Abstract

Pentamidine isethionate is a diamidine compound used in the treatment of a number of parasitic diseases, notably Pneumocystis carinii pneumonia. Although cases of sudden death have been reported during the administration of pentamidine, there have been no reported cases in the literature of pentamidine-associated arrhythmias. Reported in this study are two cases of torsade de pointes occurring during the prolonged administration of pentamidine. In addition, electrocardiographic changes of marked QT interval prolongation, pronounced precordial T wave abnormalities, and ST segment changes were shown in both patients. Mild hypomagnesemia coexisted in both cases, but torsade de pointes persisted in one patient and electrocardiographic changes remained in both cases despite magnesium replacement. QT interval prolongation and electrocardiographic abnormalities resolved slowly over several days to weeks, paralleling the known elimination kinetics of pentamidine. These data suggest a proarrhythmic effect of pentamidine isethionate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499072     DOI: 10.1016/0002-9343(87)90774-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Pentamidine reduces hERG expression to prolong the QT interval.

Authors:  Jason S Cordes; Zhuoqian Sun; David B Lloyd; Jenifer A Bradley; Alan C Opsahl; Mark W Tengowski; Xian Chen; Jun Zhou
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

3.  Ventricular repolarization time indexes following anthracycline treatment.

Authors:  B Sarubbi; M Orditura; V Ducceschi; F De Vita; L Santangelo; F Ciaramella; G Catalano; A Iacono
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

Review 4.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

5.  Torsades de pointes during intravenous pentamidine isethionate therapy.

Authors:  P Mitchell; P Dodek; L Lawson; M Kiess; J Russell
Journal:  CMAJ       Date:  1989-01-15       Impact factor: 8.262

Review 6.  Pentamidine. A risk-benefit analysis.

Authors:  B Wispelwey; R Pearson
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

7.  Molecular determinants of pentamidine-induced hERG trafficking inhibition.

Authors:  Adrienne T Dennis; Lu Wang; Hanlin Wan; Drew Nassal; Isabelle Deschenes; Eckhard Ficker
Journal:  Mol Pharmacol       Date:  2011-11-01       Impact factor: 4.436

8.  Myocardial dysfunction in patients infected with HIV: prevalence and risk factors.

Authors:  A J Jacob; G R Sutherland; A G Bird; R P Brettle; C A Ludlam; A McMillan; N A Boon
Journal:  Br Heart J       Date:  1992-12

Review 9.  QT prolongation with antimicrobial agents: understanding the significance.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Chronic pentamidine aerosol prophylaxis does not induce QT prolongation.

Authors:  C Thalhammer; J R Bogner; G Lohmöller
Journal:  Clin Investig       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.